| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, IM Karaye, T Veos The Lancet, 2023 | 991 | 2023 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, IM Karaye, GBDCRF Collaborators, ... The Lancet 400 (10352), 563-591, 2022 | 486 | 2022 |
| The impact of social vulnerability on COVID-19 in the US: an analysis of spatially varying relationships IM Karaye, JA Horney American journal of preventive medicine 59 (3), 317-325, 2020 | 446 | 2020 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019 BS Sheen, L Heibert, H Han, IM Karaye, I Yunusa, GBDHB Collaborators, ... The Lancet Gastroenterology & Hepatology, 2022 | 381 | 2022 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, IM Karaye, GBDA Collaborators, ... The Lancet, 2022 | 295 | 2022 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, IM Karaye, R Abd-Rabu, JM Acuna, ... The lancet. Gastroenterology & hepatology 7 (7), 627, 2022 | 285 | 2022 |
| Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, GT Culbreth, IM Karaye, I Yunusa, GBDO Collaborators The Lancet Rheumatology, 2023 | 230 | 2023 |
| Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 AE Micah, K Bhangdia, IE Cogswell, D Lasher, IM Karaye, ... The Lancet Global Health, 2023 | 158 | 2023 |
| Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021 AM Thomson, TA McHugh, IM Karaye, C Teply, N Lonberg, VV Tella, ... The Lancet Haematology, 2023 | 156 | 2023 |
| Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 S Momtazmanesh, SS Moghaddam, IM Karaye, S Ghamari, ... eClinicalMedicine, 2023 | 149 | 2023 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, IM Karaye, R Xu, D Lu, HJ Henrikson, JM Kocarnik, ... The Lancet Oncology 23 (1), 27-52, 2022 | 149 | 2022 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 H Kyu, A Vongpradith, SB Sirota, IM Karaye, GBDLRI Collaborators The Lancet Infectious Diseases, 2022 | 129 | 2022 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, IM Karaye, E Nichols, B Cao, C Servili, ... The Lancet Neurology, 2024 | 119 | 2024 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 WM Gardner, C Razo, MH TA, IM Karaye, GBDA Collaborators The Lancet Haematology, 2023 | 118 | 2023 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 106 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, IM Karaye, C Abbafati, J Abbas, ... The Lancet, 2024 | 94 | 2024 |
| The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of … AF Awedew, H Han, B Abbasi, IM Karaye, GBDBPH Collaborators The Lancet Healthy Longevity, 2022 | 93 | 2022 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global … YH Shin, J Hwang, IM Karaye, SW Lee, MS Kim, GBDAD Collaborators, ... Allergy, 2023 | 78 | 2023 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 75 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 69 | 2024 |